SCHEMBL6668508

SCHEMBL6668508

CCN(CC)C(C)N=C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11852482 0.75 TRPA1 (0.48)
SCHEMBL3730646 0.73
Hydrochloric Acid SCHEMBL7740179 0.71
SCHEMBL1828881 0.70
Hydrochloric Acid SCHEMBL6017809 0.70 CYP1A2 (0.32)
Hydrochloric Acid SCHEMBL27585407 0.69
SCHEMBL5668288 0.69
SCHEMBL1851718 0.67
SCHEMBL2764877 0.65
SCHEMBL17599756 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071160-A1 SCALABLE BIOREACTOR SYSTEMS AND METHODS FOR TISSUE ENGINEERING FairCraft SAS (FR) 2026-03-12 US disclosed
US-20230012452-A1 SCALABLE BIOREACTOR SYSTEMS AND METHODS FOR TISSUE ENGINEERING FAIRCRAFT (FR) 2023-01-12 US disclosed
US-11458042-B2 Bilayered devices for enhanced healing Sharklet Technologies, Inc. (US) 2022-10-04 US disclosed
EP-4004180-A1 SCALABLE BIOREACTOR SYSTEMS AND METHODS FOR TISSUE ENGINEERING Vitrolabs Inc (US) 2022-06-01 EP disclosed
WO-2004020584-A2 ANTAGONISTS OF CHEMOKINE RECEPTORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-03-11 WO disclosed